Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies.

@article{Haukeland2012FetuinAI,
  title={Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies.},
  author={John Willy Haukeland and Tuva B\orresdatter Dahl and Arne Yndestad and Ivar Prydz Gladhaug and Else Marit L\oberg and Terese K Haaland and Zbigniew Konopski and Cecilie Wium and Erlend Tuseth Aasheim and Odd Erik Johansen and P{\aa}l Aukrust and Bente Halvorsen and K{\aa}re Inge Birkeland},
  journal={European journal of endocrinology},
  year={2012},
  volume={166 3},
  pages={503-10}
}
OBJECTIVE Fetuin A has been associated with insulin resistance and the metabolic syndrome. We therefore explored the role of fetuin A in nonalcoholic fatty liver disease (NAFLD). DESIGN Cross-sectional and intervention studies. METHODS We included 111 subjects with histologically proven NAFLD of whom 44 participated in a randomized, controlled trial with metformin. One hundred and thirty-one healthy subjects and 13 subjects undergoing hepatic surgery for metastatic cancer served as controls… CONTINUE READING